Ettore Beghi
Istituto Di Ricerche Farmacologiche Mario Negri · IRCCS Istituto di ricerche farmacologiche Mario Negri di Milano
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Ettore Beghi as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 05:24 UTC. Open this list on ClinicalTrials.gov
- Ph4NCT03689114 · Low vs. Standard Daily Doses of Antiepileptic Drugs in Newly Diagnosed, Previously Untreated Epilepsy(STANDLOW)Mario Negri Institute for Pharmacological Research · completed · Epilepsies, Partial · principal investigator
- Ph2NCT03456882 · The Effect of RNS60 on ALS BiomarkersMario Negri Institute for Pharmacological Research · completed · Amyotrophic Lateral Sclerosis · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 05:24 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 05:24 UTC. The ranking covers the 200 most relevant of 38 PubMed records, and a shared surname and initials can bring in a namesake. All 38 on PubMed
- Polypill Strategy in Secondary Cardiovascular Prevention.N Engl J Med · 2022247 citationsRCR 18.6
- Treatment of first tonic-clonic seizure does not improve the prognosis of epilepsy. First Seizure Trial Group (FIRST Group).Neurology · 1997195 citationsRCR 7.4
- Intravenous immunoglobulin versus intravenous methylprednisolone for chronic inflammatory demyelinating polyradiculoneuropathy: a randomised controlled trial.Lancet Neurol · 2012164 citationsRCR 6.5
- 110 citationsRCR 4.1
- 95 citationsRCR 3.9
- 90 citationsRCR 3.5
- Adjunctive therapy versus alternative monotherapy in patients with partial epilepsy failing on a single drug: a multicentre, randomised, pragmatic controlled trial.Epilepsy Res · 200389 citationsRCR 2.7
- Physical activity and amyotrophic lateral sclerosis: a European population-based case-control study.Ann Neurol · 201484 citationsRCR 3.1
- Lithium carbonate in amyotrophic lateral sclerosis: lack of efficacy in a dose-finding trial.Neurology · 201080 citationsRCR 2.0
- Randomized double-blind placebo-controlled trial of acetyl-L-carnitine for ALS.Amyotroph Lateral Scler Frontotemporal Degener · 201373 citationsRCR 2.5